demonstrated that in GBM CSCs, VEGF inhibits cell invasiveness by blocking HGF receptor (Met)/VEGFR2 interaction and recruiting PTP1B phosphatase, which promotes Met dephosphorylation. The gene discussed is VEGFA; the disease is glioblastoma.